Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy.
Phase of Trial: Phase I/II
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Pirfenidone (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2011 Results published in the Journal of the American Society of Nephrology.
- 10 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.